Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou, Ting Yu, Ronghui Du et al. · The Lancet · 2020 · 29.1K citations · Full text

Veterinary Medicine, Health Sciences, Infectious Diseases +12

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Zhe Xu, Lei Shi, Yijin Wang et al. · The Lancet Respiratory Medicine · 2020 · 8.9K citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Virology +11

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen, Di Wu, Wei Guo et al. · Journal of Clinical Investigation · 2020 · 5.1K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Current concepts in the diagnosis and management of cytokine release syndrome

Daniel W. Lee, Rebecca Gardner, David Porter et al. · Blood · 2014 · 2.8K citations

Life Sciences, Immunology, Molecular Medicine +14

Effective treatment of severe COVID-19 patients with tocilizumab

Xiaoling Xu, Mingfeng Han, Tiantian Li et al. · Proceedings of the National Academy of Sciences · 2020 · 2.8K citations · Full text

Life Sciences, Immunology, Pharmacology +17